Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk
NCT ID: NCT01781416
Last Updated: 2014-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
799 participants
OBSERVATIONAL
2013-11-30
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study has been designed :
* to assess the level of concordance between patients' cardiovascular risk perception and the cardiovascular risk evaluated by the physicians,
* and to evaluate the impact of patients' exposure to a medical information leaflet on patients' cardiovascular risk perception.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brazilian inteRvention to Increase eviDence usaGe in practicE - Cardiovascular Prevention
NCT02851732
Influence of Additional Physician's Consultations and Short Message Service (SMS) Reminders to Patient Compliance
NCT04863274
Risk Assessment and Treat Compliance in Hypertension Education Trial
NCT00694239
Evaluating the Effectiveness of a Computerized Medication Adherence System at Reducing Cardiovascular Disease Risk Factors
NCT00796172
Perceive and Calculated CV Risk
NCT05693857
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Usually treated by the GP
* Having signed the information and consent form
Exclusion Criteria
* Patient unable to read and complete the study documentation
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Atul PATHAK, Professor
Role: STUDY_CHAIR
Service de Pharmacologie Clinique - Unite INSERM U 1048 - Faculte de Medecine - 37 Allees Jules Guesde -31073 Toulouse- FRANCE
Nicolas DANCHIN, Professor
Role: STUDY_CHAIR
Unite des Maladies Coronaires - Hopital Europeen Georges Pompidou - 20 Rue Leblanc - 75015 Paris - FRANCE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-CFR-XXX-2012/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.